Study: Orphan Drugs Offer ‘Larger Health Gains’ Over Non-Orphan Drugs
April 30, 2020
A recent study led by Tufts CEVR’s James Chambers suggests orphan drugs “offer larger health gains than non-orphan drugs.”
However, the study found that due to their high costs, orphan drugs tend to be less cost-effective.
To learn about the study, click here.